Replies to post #10881 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

NUVO is a counterexample I know of off the top of my head. This topic has already been discussed on this board ad nauseam.

[go seek]

FWIW... a RS split may not be needed

no one can predict the future, but "the possibility" exists a solid partnership will remedy the delisting concern.

IMHO, this is likely.

Then company would announce no plans to RS
an announcement of no RS is usually positive short term :)